Biovie Inc (BIVI) Stock Analysis

Biovie Inc (BIVI) is a publicly traded company in the HEALTHCARE sector. It trades at $1.70, carries a market capitalization of $11.24M. This page summarizes the public market data, fundamentals, and frequently asked questions for BIVI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.70
• Market Cap: $11.24M
• EPS: $-3.79
• 52-Week High: $12.10
• 52-Week Low: $1.06

Market Sentiment

Biovie Inc currently has a Bullish sentiment score of 0.24.

About Biovie Inc

Biovie Inc. is a clinical-stage biotechnology company located in Santa Monica, California, dedicated to the discovery, development, and commercialization of innovative drug therapies targeting complex diseases with significant unmet medical needs. Utilizing its proprietary technologies, BioVie is strategically expanding its therapeutic portfolio to capitalize on emerging opportunities within the biopharmaceutical sector. Currently advancing through multiple clinical trials, the company is foc...

GNG Research Analysis

GNG Research scores Biovie Inc (BIVI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BIVI.

Frequently Asked Questions

Does BIVI pay dividends?

Biovie Inc (BIVI) does not currently pay a regular dividend.

What is BIVI's market cap?

Biovie Inc (BIVI) has a market capitalization of $11.24M with a current stock price of $1.70.